Emergent BioSolutions shares rose after the company disclosed that it will supply additional doses of CNJ-016, a treatment ...

Final analysis of the INTRIGUE trial shows ripretinib offers similar survival rates and better safety compared to sunitinib ...

The CDK2 inhibitor INCB123667 showed positive efficacy and safety signals in platinum-resistant/refractory ovarian cancer.

Emergent BioSolutions has inked a deal to acquire a smallpox treatment for up to $325 million, giving the Gaithersburg firm another avenue to feed the U.S. national stockpile.

The examination shows that Emergent secured contracts to supply an unproven medical treatment at a time when the mission of protecting U.S. diplomats against chemical attacks had taken on fresh ...

The clinical research will evaluate if treatment with Emergent's antibody product will help protect high-risk individuals and limit the spread of COVID-19.

Emergent BioSolutions Inc said the U.S. Food and Drug Administration approved its treatment for inhaled anthrax, triggering a $7 million milestone payment from the U.S. Department of Health and ...

Harvey Weinstein is back in the hospital after receiving an "alarming blood test result." On Monday, Weinstein's attorney confirmed that the disgraced mogul was receiving "emergent treatment ...

GAITHERSBURG, Md., April 02, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today provided an update on the evaluation of its investigational SARS-CoV-2 Immune Globulin Intravenous ...

Harvey Weinstein has been taken back to Bellevue Hospital for “emergent treatment” related to an “alarming blood test result,” his spokesperson and attorney said Monday. “Harvey ...